共 12 条
[1]
Lycopene treatment against loss of bone mass; microarchitecture and strength in relation to regulatory mechanisms in a postmenopausal osteoporosis model.[J].Mohammed-Salleh M. Ardawi;Mohammed H. Badawoud;Sherif M. Hassan;Abdulrahim A. Rouzi;Jumanah M.S. Ardawi;Nouf M. AlNosani;Mohammed H. Qari;Shaker A. Mousa.Bone.2016,
[4]
Homocysteine alters the osteoprotegerin/RANKL system in the osteoblast to promote bone loss: pivotal role of the redox regulator forkhead O1.[J].Viji Vijayan;Mayuri Khandelwal;Kapil Manglani;Rajiv Ranjan Singh;Sarika Gupta;Avadhesha Surolia.Free Radical Biology and Medicine.2013,
[6]
IL-1 α and IL-1 β Levels in Blood Serum and Saliva of Menopausal Women.[J].Mansur Rahnama;Izabela Jastrz?bska;Rafa? Jamrogiewicz;Janusz Kocki.Endocrine Research.2012, 2
[7]
Effects of administration of hormone therapy or raloxifene on the immune system and on biochemical markers of bone remodeling
[J].
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY,
2012, 19 (03)
:319-327
[8]
[9]
[10]

